TABLE 3.
Overall | P-value | PV | P-value | Extra-PV | P-value | ||||
|
|
|
|||||||
Smax < 1.4 (†n = 13) | Smax ≥ 1.4 (†n = 12) | Smax < 1.4 (†n = 13) | Smax ≥ 1.4 (†n = 12) | Smax < 1.4 (†n = 13) | Smax ≥ 1.4 (†n = 12) | ||||
Baseline mean DF (Hz) | 7.958 (7.138, 8.485) | 7.708 (7.194, 8.013) | 0.650 | 7.797 (6.246, 8.243) | 7.338 (6.382, 8.061) | 0.689 | 8.103 (7.796, 8.599) | 7.836 (7.220, 8.385) | 0.503 |
Post-AAD Mean DF (Hz) | 6.986 (6.011, 7.677) | 6.584 (5.801, 7.015) | 0.014 | 6.732 (5.013, 7.534) | 5.963 (5.430, 6.815) | 0.039 | 7.225 (6.411, 7.781) | 6.818 (5.859, 7.168) | 0.002 |
Post-AAD COV-DF (%) | 141.000 (104.000, 141.000) | 141.000 (110.000, 141.000) | 0.656 | 141.000 (116.500, 141.000) | 141.000 (131.500, 141.000) | 0.532 | 141.000 (96.600, 141.000) | 140.000 (91.900, 141.000) | 0.371 |
DF, Dominant Frequency; COV-DF, Coefficient of Variation-Dominant Frequency.
Patients who did not sustain proper normal sinus rhythm and an AF status were excluded from the analysis.
Median (IQ1, IQ3) was displayed in the Table.
†n = The number of patients × AAD × Dose.